3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
6
Thoracic
3
Gastrointestinal
3
Other solid neoplasm
2
NET
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Carcinoma, Renal Cell
4
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thrombocytosis
1
Tertiary Lymphoid Structures
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Interventions
Filgrastim
13
Carboplatin
10
Cyclophosphamide
9
pembrolizumab
8
Radiosurgery
8
Ifosfamide
8
Magnetic Resonance Spectroscopy
7
Etoposide
7
Biopsy
7
Specimen Handling
6
Doxorubicin
6
X-Rays
5
Phantoms, Imaging
5
Peripheral Blood Stem Cell Transplantation
5
Paclitaxel
5
Granulocyte Colony-Stimulating Factor
5
Gemcitabine
5
Cisplatin
5
pazopanib
4
palbociclib
4
Thiotepa
4
Temozolomide
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Mesna
4
Melphalan
4
Docetaxel
4
Busulfan
4
Blood Specimen Collection
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
regorafenib
×
Genitourinary
×
Clear all
NCT03475953
2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2
Unknown
747 enrolled